#USA #Jersey City #BioNJ #BioPartnering #Liberty Science Center

BioNJ's 16th Annual BioPartnering Conference

BioNJ is set to host its 16th Annual BioPartnering Conference on May 12, 2026, at the iconic Liberty Science Center in Jersey City, NJ. This event aims to unite key players in the life sciences sector, including executives, investors, academic collaborators, and business development professionals. The conference is designed to provide high-impact networking opportunities and engaging discussions.

Key Features of the Conference

The agenda is packed with activities tailored to inspire collaboration and innovation. Attendees can look forward to:

• - 11 Partnering Sessions: These sessions will facilitate meaningful meetings between venture capitalists and life sciences companies.
• - Industry Connections: A unique feature where attendees have office hours with major biopharma firms, opening doors to potential partnerships.
• - Startup Pitch Sessions: Nearly 90 pioneering companies will present their innovative ideas and business models, showcasing the latest advancements in the life sciences field.
• - Plenary Sessions: These will include insightful talks from notable thought leaders, covering significant topics that shape the industry.
• - Interactive exhibits to encourage knowledge sharing and networking

Exciting Collaborations

Debbie Hart, President and CEO of BioNJ, expressed enthusiasm about collaborating again with organizations like J.P. Morgan, Morgan Lewis, and CoreWeave. These partners share a vision aimed at fostering a robust life sciences ecosystem that advances the development of new treatments and therapies for patients.

“This year's conference is set to be our most impactful yet,” Hart stated, reflecting on last year's success, which saw nearly 600 professionals from 16 states and 13 countries participating. This momentum is expected to continue, with confirmations from delegations from Canada and Israel already secured for this year's event.

Engaging Industry Leaders

The event will feature presentations from prominent figures in the industry:

• - Parsa Amiri, Investment Analyst at SOSV
• - Jackie Berman, Partner at Morgan Lewis
• - Max Colbert, Senior Associate at Medical Excellence
• - Debbie Hart, President and CEO of BioNJ
• - Louise Ruihau Liu, CEO of Hill Research, among others.

These leaders will offer insights into current trends and strategies vital for success in the competitive life sciences landscape.

Relevant Topics of Discussion

This year’s agenda includes compelling themes such as:

• - Evolving FDA Approval Strategies
• - The role of AI in real-world life sciences applications
• - Mergers and Acquisitions strategies while building value in life sciences
• - Life Sciences Investor Reverse Pitch: Transitioning from seed funding to growth

Networking Opportunities

Participants can engage with numerous investors actively seeking new ventures. The Industry Connections Desk will again facilitate one-on-one meetings for Company Presenters and BioNJ Entrepreneur/Innovation Members with business development representatives from major companies like Bristol Myers Squibb and Pfizer. These sessions aim to forge new partnerships and explore opportunities for collaboration.

The conference is recognized as a leading event in the region's life sciences calendar. Registration is available now with fees set at $475 for BioNJ members and $575 for non-members. To learn more and register, please visit BioNJ.org/BioPartnering.

For inquiries, contact Ann Wieczkowski at [email protected] or call 609-890-3185.

Conclusion

The BioPartnering Conference not only highlights the innovative spirit of the life sciences industry but also offers a platform for collaboration and growth. As stakeholders from various sectors converge at the Liberty Science Center, the potential for new partnerships and advancements in health is brighter than ever.